Psychiatry and Neurology, Neurology · East Brunswick, NJ
NPI
1841220829
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6 Cornwall Court, Suite E
East Brunswick, NJ, 08816
Phone (732) 257-0003
Groups this clinician bills Medicare through
Medicare paid, 2024
$320K
3,541 services
Medicare patients, 2024
680
Average age 79
Drug cost, 2024
$1.2M
3,376 prescriptions
Company payments, 2025
$1,867
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yan Lupyan was code J0585 (injection, onabotulinumtoxina, 1 unit), 615 times for 13 patients. In total Yan Lupyan billed 3,541 services in 56 codes, and Medicare paid $320K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 615 | 13 | $4.94 | $3,041 |
| 99214 Office E&M - Established | Office | 478 | 320 | $104.23 | $50K |
| 99213 Office E&M - Established | Office | 278 | 176 | $73.70 | $20K |
| 95886 Electrical Nerve Conductivity | Office | 265 | 128 | $79.31 | $21K |
| 99204 Office E&M - New | Office | 198 | 198 | $136.31 | $27K |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 193 | 21 | $57.83 | $11K |
| 95816 Neurologic | Office | 143 | 141 | $332.44 | $48K |
| 20610 Joint Injection | Office | 131 | 36 | $72.67 | $9,520 |
| 95910 Electrical Nerve Conductivity | Office | 124 | 119 | $144.24 | $18K |
| 77002 Imaging - Miscellaneous | Office | 118 | 28 | $98.02 | $12K |
| 95923 Electrical Nerve Conductivity | Office | 106 | 105 | $101.42 | $11K |
| 95921 Electrical Nerve Conductivity | Office | 105 | 104 | $70.47 | $7,400 |
| 99442 Telephone Services | Office | 102 | 82 | $73.98 | $7,546 |
| 99443 Telephone Services | Office | 92 | 74 | $104.46 | $9,611 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 64 | 51 | $12.75 | $816 |
By year: 2022 $431K for 8,771 services; 2023 $399K for 5,831 services; 2024 $320K for 3,541 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yan Lupyan prescribed most often to Medicare patients was Donepezil Hcl, with 320 prescriptions and refills. In total Yan Lupyan wrote 3,376 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 320 | 401 | 68 | $1,961 |
| Sertraline Hcl Generic | 294 | 364 | 73 | $787 |
| Gabapentin Generic | 188 | 221 | 74 | $1,073 |
| Levetiracetam Generic | 159 | 199 | 27 | $2,520 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 155 | 197 | 33 | $2,355 |
| Memantine Hcl Er Memantine Hcl | 144 | 195 | 29 | $12K |
| Qulipta Atogepant | 129 | 133 | 32 | $135K |
| Ubrelvy Ubrogepant | 123 | 138 | 34 | $228K |
| Nurtec Odt Rimegepant Sulfate | 109 | 113 | 28 | $157K |
| Horizant Gabapentin Enacarbil | 105 | 105 | 28 | $78K |
| Memantine Hcl Generic | 96 | 146 | 21 | $1,392 |
| Doxepin Hcl Generic | 83 | 83 | 39 | $20K |
| Pregabalin Generic | 81 | 81 | 15 | $1,565 |
| Ztlido Lidocaine | 75 | 76 | 27 | $30K |
| Lamotrigine Generic | 60 | 76 | 11 | $389 |
Brand drugs: 968 claims; generic drugs: 2,408 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yan Lupyan $1,867 ($1,867 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $436.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $436 |
| Axsome Therapeutics, Inc. AXSM | 16 | $378 |
| Eisai Inc. 4523.T | 10 | $302 |
| Pfizer Inc. PFE | 8 | $279 |
| Azurity Pharmaceuticals, Inc. | 7 | $157 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $79.15 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $68.83 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $50.23 |
| Impel Pharmaceuticals LLC | 1 | $39.46 |
| Lundbeck LLC | 1 | $38.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.